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abstract – The main post-polio syndrome (PPS) symptoms are new-onset weakness, new-onset atrophy, 
fatigue, cold intolerance, and pain associated with sleep disturbances. The polysomnographic study is the gold 
pattern to analyze sleep disorders.  Objective: To assess pain, intolerance to cold and periodic limb movements 
(PLM) index before and after the use of MIG3 bioceramic fabrics over 4 weeks.  Method: 12 patients with 
PPS from UNIFESP/EPM. All patients were submitted to polysomnography and infra-red examinations with 
answered scales of pain and intolerance to cold before and after the use of MIG3 bioceramics fabrics.  Results: 
There were significant decreases in pain and PLM index.  Conclusion: MIG3 bioceramic fabrics can help in the 
treatment of pain and PLM in PPS patients.
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Efeitos do uso de tecidos com biocerâmica MIG3 – emissora de infravermelho longo – na dor, intolerância 
ao frio e movimentos periódicos dos membros na síndrome pós-poliomielite
resumo – dentre as manifestações clínicas da SPP destacam-se nova fraqueza, fadiga, dor, intolerância 
ao frio, nova atrofia e transtornos do sono. A polissonografia de noite inteira permanece sendo padrão 
ouro para análise do sono e diagnóstico de transtornos do sono.  Objetivo: Avaliar o comportamento da 
dor, intolerância ao frio (IF) e índice de movimentos periódicos de membros (PLMs) após uso de colchonete 
e roupas com biocerâmica MIG3 por 4 semanas.  Método: 12 pacientes com SPP, da UNIFESP/EPM. Todos 
realizaram exames de polissonografia e infravermelho e responderam a questionários de dor e IF antes e após 
o uso dos materiais.  Resultados: Houve diminuição significativa da dor e dos PLMs.  Conclusão: os tecidos com 
biocerâmica MIG3 podem ser um coadjuvante ao tratamento da dor e dos PLMs nos pacientes com SPP.
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Poliomyelitis is a viral disease that is typically pres-
ent during the biphasic phase, with headache, fever and 
gastrointestinal symptoms, followed days later by impair-
ment of the motor neurons of the spinal cord, which may 
lead to paralysis, usually involving lower limbs in an asym-
metrical and non-proportional way1. Post-polio syndrome 
(PPS) is characterized by the development of new neuro-
muscular symptoms that occur after a stability of at least 
15 years in patients with previous acute polio paralysis. 
These symptoms include: (1) new onset of muscular weak-
ness and new onset of limb and bulbar or respiratory mus-
cular atrophy [post-polio muscular atrophy (PPMA)], and 
(2) excessive fatigue and diminished physical resistance. 
Besides these symptoms, joint and muscle pain, intoler-
ance to cold and sleep disturbances (obstructive and cen-
tral apneas, periodic limb movements – PLM) frequent-
ly occur. PPS is a clinical diagnosis that requires exclusion 
of other clinical, neurological, orthopedic or psychiatric 
illnesses that could account for the new symptoms2. PPS 
is a slowly progressive phenomenon, with a stability pe-
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riod higher than 15 years, which may represent up to 70% 
of acute paralytic polio survivors3-5. Sleep disturbances 
have been described alongside PPS for decades. Usually, 
periodic limb movements occur during the first hours of 
sleep. The movements include feet dorsal flexure and tri-
ple flexion of lower limbs6,7. Patients who experience PLM 
report paresthesias from calves to thighs, with arms being 
rarely involved. The symptoms are usually symmetrical-
ly and bilaterally reported. This feeling can be felt inside 
the leg and can be described as sliding, dragging, discom-
fort, restlessness or nervousness7,8. The patient may pres-
ent a long asymptomatic period. depression and sleep 
disturbances are resulting elements7-9. The prevalence in 
the general population is around 5%. Period limb move-
ments during sleep are an independent nosological enti-
ty. These episodes occur more frequently in the first half 
of the night and provoke arousals from sleep. They lead 
to sleep fragmentation, unrefreshed sleep and daytime 
hyper somnolence8,10.
In the healthcare field, the effects of luminous radi-
ation on the tissues are well known. Through the action 
of visible (red) or invisible (infrared) light, luminous radi-
ation promotes a molecular vibration, leading to an in-
crease in the tissue metabolism, called biostimulation. ra-
diation acts by increasing the cell membrane permeabil-
ity, favoring the exchange of metabolites as extracellu-
lar medium, and by nurturing the cells. It acts on the mi-
tochondria, favoring the ATP synthesis and, consequent-
ly, stimulating the synthesis of proteins such as collagen 
and elastin. It also enhances cell division. In order to pro-
voke this increase in metabolism, the extracellular medi-
um is required to be healthy. Infrared stimulates chemi-
cal mediators and hormones that will act on the control 
of edema, pH, oxygen free radicals and microcirculation, 
fostering the required conditions for the increase in the 
cell metabolism11,12.
MIG3 bioceramics, an infrared emitter, incorporated in 
clothes (gloves, shorts, dressings), allows its use at home, 
in a simple and non-invasive way, at work, and even during 
sleep, thereby facilitating a patient’s daily life. recent evi-
dence claims that it can control pain, inflammation, accel-
erate healing in the post-operative period, and minimize 
the use of drugs and its side effects, through self-regula-
tion mechanism12-16.
The objective of this study is evaluate the impact of 
the use of MIG3 bioceramic over four weeks on pain, in-
tolerance to cold and periodic leg movement in patients 
with post-polio syndrome.
MEthod
Twelve patients with post-polio syndrome from the Polio-
myelitis and PPS outpatient clinic of the Neuromuscular diseas-
es department of UNIFESP/EPM (Table 1) were evaluated accord-
ing to the Mulder post-polio syndrome criteria. These patients 
were asked to use MIG3 bioceramics fabrics (portable mattress, 
shirts, dressings and shorts) during 4 weeks. 
The polysomnography exam was performed at the beginning 
of the treatment and soon after its end in our sleep institute.
The infrared exam was performed before the treatment on-
set and soon after its completion, at the Nove de Julho Hospital, 
by a specialist in pain diagnostics. In order to perform the exam, 
patients had to stay in a air conditioned room during 30 min-
utes, for stabilization of the body temperature, at 20oc and 55% 
of air relative humidity, with an air speed lower than 0.2 m/s to 
prevent evaporation and subsequent skin thermal loss by forced 
convection, seated or standing, when possible, without clothes 
on the upper and lower body parts (only underwear), for the sta-
bilization of the cutaneous body temperature.
Long hair was tied back to avoid image interference. during 
the period in which they were sat or remained standing, the pa-
tient was not allowed to touching his/her trunk with the hands 
or any other surface.
Subsequently, by infrared images of anterior, lateral, posteri-
or and oblique incidences were obtained, horizontally position-
ing the infrared camera at a 1 meter distance and vertically ad-
justed in horizontal line with the patient’s body.
The Ir images were captured by the infrared sensor of 160 × 
120 resolution with 20o lenses. The thermal sensitivity employed 
was 0.1oc by color shade, using a rain-type colorimetric scale 
(palette). The colors are, from warmer to colder, white, pink, red, 
orange, yellow, light green, dark green, light blue, dark blue, pur-
ple and black, directly indicating the distribution level of local 
cutaneous blood perfusion. All images were exposed with the 
palette side by side for consulting reasons, when comparable 
within the same upper and lower temperature thresholds.
Pain and intolerance to cold were quantified through ana-
logical visual scales (AvS).
Statistical analysis
data were analyzed comparing the average temperature val-
ues in T0 and T4, looking for a evidence of MIG3 fabrics use. The 
bimodal pared t-test was used for an α error of 0.05. There were 
also evaluated the AvS values and polysomnographic parameters 
before and after the use of MIG3 fabrics using respectively chi-
squared test and pared t-test (considering p<0.05 and α=0.05).
Table 1. Demographic data.
PPS patients
# 12
Mean age (years ± Sd) 46.25±8.82
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rEsults
we found a significant decrease in pain intensity (8.3±2.5 
vs. 3.8±2.5). A slight non-significant decrease in intoler-
ance to cold was also observed (6.4±2.3 vs. 5.3±2.4) (Fig 2).
The polysomnographic exam demonstrated a signifi-
cant decrease in the PLM index (11±14 vs. 3.7±6.3), a signifi-
cant decrease in the heart rate (Hr) during wake (83±17 vs. 
72.2±10.8), rEM sleep (75±14 vs. 66.7±10.4) and non-rEM 
(77±14 vs. 66±11) sleep periods (Table 2).
The infrared exam did not show a significant decrease 
in the subcutaneous temperature range after the use of 
fabrics with MIG3 bioceramics; however, there was an im-
provement in intolerance to cold clues and complaints of 
pain (Fig 2).
dIscussIon
The radiation emitted by long infrared (LIr) fabrics in-
creases membrane permeability and the calcium concen-
tration in the cell membrane and cytoplasm; it biological-
ly stimulates the cell, favoring the exchange of metabo-
lites within the extracellular medium, nurturing the cell. 
It also acts on mitochondria, promoting the ATP synthe-
sis used in muscular contraction16.
The muscle-skeletal system is also benefited by the ef-
fects of LIr, so that its application promotes a decrease 
in muscle spasms, as well as muscle relaxation. The met-
abolic rate may suffer an increase of about 13% for each 
rise of 1oc in the tissue temperature, and the increase in 
metabolism will be higher in the region where most of 
the heat is generated. As a result of this, there is a high tis-
sue demand for oxygen and nutrients, resulting in an in-
crease in the catabolic products clearance17 and in stimu-
lation for substance release, such as endorphins and en-
docephalines which are provided with analgesic proper-
ties similar to those of morphine18. due to these analge-
sic properties of MIG3 bioceramics, long infrared emitter, 
Table 2. Sleep quality.
Polisomnographic parameters
Pre-treatment night  
N=12 
Mean ± Sd





Sleep efficiency, % 72±14.0 72.6±8.9 NS
rEM latency, min 130±89 161± 99 NS
Stage 1, % 4.3±2.9 5.7±4.3 NS
Stage 2, % 66.6±12.1 62.2±13.3 NS
Stage 3, % 2.1±2.2 3.8±2.5 p<0.05
Stage 4, % 8.4±8.6 11.9±7.8 NS
rEM sleep, % 16.3±8.3 19±6.7 p<0.05
Arousal index, n/h 13.0 ±10 11.8±7.8 NS
TTS, min 331± 75 324.5±53.6 NS
Sleep latency, min 48.0±40 32.3±19.3 NS
PLM index, n/h 11±14.0 3.7±6.3 P<0.05
rr awake, bpm 18±3 14.7±2.6 NS
rr rEM, bpm 15±4 15.2±3.4 NS
rr NrEM, bpm 22±18 15.5±3 NS
Hr NrEM, bpm 77±14 66±11 p<0.05
Hr rEM, bpm 75 ±14 66.7±10.4 p<0.05
Hr awake, bpm 83 ±17 72.2±10.8 p<0.05
Fig 1. Pain visual analogical scale.
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the significant improvement in pain complaints can be ex-
plained in patients assessed. 
The main effects of long infrared include improved 
circulation, increased immunity, repair and regeneration 
of tissues and the regulation of body fluids (humoral sys-
tem). The rise in body temperature and increased mobili-
ty of body fluids14, in addition to pain relief, are also some 
consequences of LIr15. A significant improvement of in-
tolerance to cold was expected in patients with PPS due 
to enhanced circulation, but this improvement may not 
reached due to peripheral muscle atrophy, but also to im-
pairment in the body temperature regulatory centers of 
the central nervous system. 
This study demonstrated that the use of fabrics im-
pregnated with MIG3 bioceramics, when in contact with 
the skin during the sleep period, can alter sleep quality. 
we found that there was a significant improvement in 
PLM and Hr indexes during periods of wakefulness, rEM 
and NrEM sleep after a month of use of mattresses fit-
ted with MIG3 bioceramics. 
The most accepted cause for the occurrence of PLM 
is that there is a change in the production of dopamine, 
provoked by iron deficiency. Patients with PPP have a PLM 
index higher than the general population and in a higher 
frequency, perhaps due to injury of neurons in the brain-
stem or even of the motor neurons in the anterior horn 
of the spinal cord. 
The MIG3 bioceramics in contact with the skin is 
known to produce a vasodilatation of arteries that irri-
gate the skin and muscles, facilitating the venous return, 
and reducing the cardiac pre-load. This goes some way 
towards explaining the significant decrease in the heart 
rate before and after the use of fabrics impregnated with 
MIG3 bioceramics.
Studies performed in 1988 with the use of LIr showed 
improvement in the quality of sleep in patients and rats12. 
In 1995, studies confirmed that LIr therapy lead to an im-
provement in the quality of life, quality of sleep and 
general well-being of patients with chronic fatigue syn-
drome13. These factors may result from the increase in the 
brain temperature associated with the type of neuronal 
activation, characteristic of sleep in the hypothalamus 
and brainstem. The central nervous system excitation is 
reduced by increasing the blood temperature in the hypo-
thalamus; resulting in a somniferous effect. The improve-
ment in the symptoms is believed to be caused by the re-
duction in pain and improvement in sleep13.
To conclude, the use of fabrics and mattresses fitted 
with MIG3 bioceramics, a long infrared emitter, over four 
weeks, had significantly reduced complaints of pain and 
improved sleep quality. There was also a significant reduc-
tion in PLM and heart rate indexes. Future studies should 
aim at enhancing our current data base on this exciting 
research area.
Fig 2. Adjustment of subcutaneous temperature after the use of fabrics with MIG3 bioceramics. [A] increase in the subcutane-
ous temperature in the trunk area; [B] decrease in the subcutaneous temperature of the feet and legs.
Arq Neuropsiquiatr 2009;67(4)
 1053
MIG3 bioceramics post-polio syndrome
Silva et al.
rEfErEncEs
 1. Oliveira ASB, Maynard FM. Síndrome pós-poliomielite: aspectos neu-
rológicos. São Paulo: Rev Neurociências 2002;10:31-34.
 2. Dalakas MC. Post-polio syndrome 12 years later. In: The post-polio syn-
drome: advances in the pathogenesis and treatment. Ann NY Acad Sci 
1995;753:11-18.
 3. Halstead LS. Managing post-polio: a guide to living well with post-po-
lio syndrome. Arlington VA. ABI Professional Publications, 1998.
 4. Mulder DW. Post-polio syndrome: Past, present and future. In: Munsat 
TL (Ed). Post-polio syndrome: past, present and future. Boston: Butter-
worth-Heinemann, 1991:1-8.
 5. Maynard FM, Headley JI. Manual acerca dos efeitos tardios da po-
liomielite, para médicos e sobreviventes. Associação Pós-Pólio de Por-
tugal. Col “Rumos e Perspectivas”, 2000:1.
	 6.	 Martins	PJF,	Mello	MT,	Tufik	S.	Exercício	e	sono.	Rev	Bras	Méd	Esporte	
2001:7;28-36.
 7. Martinez D. Prática da medicina do sono. BYK 1999;1:276.
 8. Montplaisir J, Laverdière M, Saint-Hilaire JM. Sleep and epilepsy: long 
term monitoring in epilepsy. EEG 1985:37(Suppl):S215-S239. 
 9. O’keeffe ST. Restless legs syndrome: a review. Arch Med Intern 1996: 
156;243-248.
10. Ekbom KA. Restless legs syndrome. Neurology 1960:10;868-873.
11. Masuko AH, Prado LBF, Prado GF. Síndrome das pernas inquietas. Rev 
Neurociências 2004;12:18-20.
12. Honda K, Inoué S. Sleep-enhancing effects of far-infrared radiation in 
rats. Int J Biometeorol 1988;32:92-94.
13. Masuda A, Kihara T, Fukudome T, Shinsato T, Minagoe S, Tei C. The ef-
fects of repeated thermal therapy for two patients with chronic fatigue 
syndrome. J Psychosomatic Res 2005;58:383-387.
14. Inoue S E, Kabaya M. Biological activities caused by far-infrared radi-
ation. Int J Biometeorol 1989;33:145-150.
15. Massayoshi Y, Takashi T. Far infrared- results and treatments for can-
cer. Tokyo Joshi Ika Daigaku Medical University. Ed. Toppan Insatsu 
Kabushiki-Kaisha-Tokyo, 1989.
16. Toyokawa H, Matsui Y, Uhara J, et al. Promotive effects of far-infrared 
ray	on	full-thickness	skin	wound	healing	in	rats.	Exp	Biol	Med	2003;	
228:724-729.
17. Kitchen S, Bazin S. Eletroterapia de Clayton. 10ª edição. São Paulo: Ma-
nole, 1998.
18. Junqueira LC, Carneiro J. Histologia Básica. 8.Ed. Rio de Janeiro: Guana-
bara Koogan, 1995.
